| 摘要 |
The invention relates to novel compounds of 4-[3-(4-arylpiperazine-1-yl)-propyl]-benzo-1,2-diamines I, 4-(3-{4-[bis-(4-fluorophenyl)-methyl]-piperidine-1-yl}-propyl)-benzo-1,2-diamine III and 8-[3-(3,4-diaminophenyl)-propyl]-1-phenyl-1,3,8-triaza-spiro[4.5]-decane-4-one V, the derivatives thereof in the form of benzimidazol-2-thiones, benzoimidazoles and chinoxaline-2,3-diones and the use thereof as pharmacologically acceptable salts as dopaminergic and serotoninergic agents and the methods for the production thereof. |
